Class I histone deacetylase inhibition is a novel mechanism to target regulatory T cells in immunotherapy

Li Shen, Roberto Pili

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Class I histone deacetylase inhibition is a novel mechanism to target regulatory T cells in immunotherapy'. Together they form a unique fingerprint.

Medicine & Life Sciences